# SDK: Enterprise Architecture & Biological Processing Framework

## Abstract

This technical specification outlines the programmatic designs, formal mathematical models, multi-layer validation pipelines, and zero-trust security architecture driving the GENESTACK SDK. 

GENESTACK is an advanced functional genomics and high-frequency biological signal compiler. It converts multidimensional phenotypic telemetry (e.g., continuous heart rate variability, sleep latency, and blood biochemistry arrays) into high-fidelity genomic expression inferences. These inferences are processed by a rule-based constraint compiler to generate highly synergistic peptide, nootropic, and compound intervention protocols tailored to individual cellular states.

---

## 1. System Philosophy & Strategic Goals

The fundamental design paradigm of GENESTACK is **"Behavior-to-Expression Status Synthesis."** Instead of relying on static genomic data alone—which provides a rigid baseline but lacks metabolic context—GENESTACK merges dynamic real-time physiological inputs with baseline genomic markers. This creates an up-to-the-minute profile of cellular regulatory environments.

```
+─────────────────────────────────────────────────────────────────────────────+
|                          GENESTACK Information Lifecycle                    |
+─────────────────────────────────────────────────────────────────────────────+
                                       
   [ High-Frequency Biomarkers & Telemetry ]      [ Static Genomic SNP Data ]
                      │                                        │
                      └───────────────────┬────────────────────┘
                                          │
                                          ▼
                         +─────────────────────────────────+
                         |     Signal Ingestion Layer      |
                         |  - Real-time rolling filtering  |
                         |  - Statistical outlier removal  |
                         +────────────────┬────────────────+
                                          │
                                          ▼
                         +─────────────────────────────────+
                         | Genomic Inference Mapping Engine |
                         |  - Expression state generation  |
                         |  - Linkage disequilibrium rules |
                         +────────────────┬────────────────+
                                          │
                                          ▼
                         +─────────────────────────────────+
                         |    Pathway Validation Engine    |
                         |  - Contraindication screening   |
                         |  - Over-activation guarding     |
                         +────────────────┬────────────────+
                                          │
                                          ▼
                         +─────────────────────────────────+
                         | Protocol Compilation & Synthesis |
                         |  - Affinity calculation         |
                         |  - Dynamic dosage scaling       |
                         +─────────────────────────────────+
```

### Core Design Principles

1. **Deterministic Processing**: All calculations map strictly to mathematical formulas, ensuring consistent inference outputs across identical datasets.
2. **Dynamic Adaptation**: The engine adjusts compound dosage recommendations dynamically based on incoming real-time telemetry changes.
3. **Decoupled Security**: No personally identifiable information (PII) enters the core calculation processing pipeline.
4. **Resilient Type Safety**: Strict TypeScript structures prevent type-casting errors and ensure stable calculations.

---

## 2. Ingestion & Preprocessing Mechanics

The ingestion layer handles real-time continuous signal processing. High-frequency biometric feeds from wearables (e.g., Oura, Whoop, Apple Health) are often noisy, requiring specialized cleaning before use.

### 2.1 Moving Gaussian Filtering

A Gaussian smoothing filter is applied to streaming metrics to reduce noise while preserving important physiological shifts:

$$G(x) = \frac{1}{\sqrt{2\pi}\sigma} e^{-\frac{x^2}{2\sigma^2}}$$

Where:
- $x$ is the sample distance from the center of the sliding window.
- $\sigma$ is the standard deviation parameter controlling smoothing strength.

```
       Raw Data Signal (with noise spikes)
                │
                ▼
  [ Windowing / Radius Calculation ]  --> Window Radius r = ceil(3 * sigma)
                │
                ▼
    [ Gaussian Kernel Smoothing ]    --> Symmetric weight assignment
                │
                ▼
     Filtered, Sanitized Data
```

### 2.2 Outlier Filtering with Z-Score Verification

To eliminate sensor anomalies without losing valid physiological trends, data points undergo Z-score analysis within a moving window:

$$\mu = \frac{1}{N}\sum_{i=1}^{N} x_i \quad \text{and} \quad \sigma = \sqrt{\frac{1}{N}\sum_{i=1}^{N} (x_i - \mu)^2}$$

Any data point where $Z = \frac{|x_i - \mu|}{\sigma} > 1.5$ is excluded from the calculation pipeline.

---

## 3. The Five Core Biological Pathways

The GENESTACK system processes data across five distinct regulatory systems. Each system maps to specific genomic single nucleotide polymorphisms (SNPs) and distinct intervention classes.

### 3.1 Dopaminergic Regulation System

Focuses on executive function, prefrontal dopamine clearance speeds, and dynamic dopamine receptor density.

- **Target Gene Markers**: `COMT` (rs4680), `DRD2` (rs1800497).
- **Phenotypic Metrics**: Executive attention scores, cognitive fatigue rates, working memory efficiency.
- **Intervention Categories**: Dopamine synthesis precursors, monoamine oxidase modulators, BDNF enhancers.

```
                             [ High Dopamine Clearance ]
                                          │
                  ┌───────────────────────┴───────────────────────┐
                  ▼                                               ▼
          [ Low Sensitivity ]                           [ Normal Sensitivity ]
         Incorporate Bromantane                        No precursors needed
```

### 3.2 Circadian Rhythmicity

Controls chronotype timing, slow-wave sleep duration, and cellular repair cycles.

- **Target Gene Markers**: `PER3` (VNTR variant), `CLOCK` (rs1801260).
- **Phenotypic Metrics**: Sleep latency, slow-wave phase amplitude, nocturnal arousal frequency.
- **Intervention Categories**: Phase-alignment modulators, nocturnal cortisol reducers.

### 3.3 Inflammatory Balance

Manages localized cytokine activity and dynamic physical stress recovery times.

- **Target Gene Markers**: `TNF-α` (rs1800629), `IL-6` (rs1800795).
- **Phenotypic Metrics**: Soreness persistence, elevated resting heart rate.
- **Intervention Categories**: Anti-inflammatory peptides, tissue regeneration promoters.

### 3.4 Anabolic signaling & Growth Axis

Evaluates cellular growth signaling, structural tissue repair, and myostatin suppression.

- **Target Gene Markers**: `IGF-1` (rs35767), `MSTN` (rs1805086).
- **Phenotypic Metrics**: Exercise adaptation rate, muscle regeneration speed.
- **Intervention Categories**: Secretagogues, peptide repair fragments.

### 3.5 Metabolic Efficiency

Determines lipid storage tendencies versus cellular caloric uncoupling.

- **Target Gene Markers**: `FTO` (rs9939609), `PPARG` (Pro12Ala).
- **Phenotypic Metrics**: Baseline metabolic rate, caloric burn efficiency, glucose response proxies.
- **Intervention Categories**: Mitochondrial modulators, metabolic partition enhancers.

---

## 4. Compilation & Safety Validation Pipeline

Once expressions are determined, the compiler computes compound recommendations. To ensure user safety, this stage uses strict cross-pathway constraint validation.

```
       [ Suboptimal Expression Profile ]
                       │
                       ▼
    +─────────────────────────────────────+
    | Compound Synthesis Selection Engine |
    +──────────────────┬──────────────────+
                       │
                       ▼
    +─────────────────────────────────────+
    |       Constraint & Safety Checks    |
    | - Dose ceilings (ThresholdManager)  |
    | - Overload warnings (OverlapEngine) |
    +──────────────────┬──────────────────+
                       │
                       ▼
           [ Validated Output Protocol ]
```

### 4.1 Contraindication Analysis

The system screens for interactions across all proposed compounds. For instance, combining multiple compounds that stimulate the same pathways triggers an immediate warning:

```
Proposed Compounds: [ Semax, Bromantane ]
Pathway Impact: Concurrent upregulation of dopamine synthesis pathways.
Mitigation Action: Adjust the dosage ceiling for both compounds.
```

### 4.2 Automated Dosage Scaling

Dosages are scaled dynamically based on a patient's inferred expression status and biometrics:

$$\text{Prescribed Dose} = \text{Base Dose} \times (1 + \text{Expression Weight Modifier})$$

Where the modifier is capped to prevent exceeding safety limits.

---

## 5. Security & Multi-Tenant Architecture

GENESTACK implements zero-trust data processing principles. All user data is fully decoupled from identifying attributes before processing.

### 5.1 Sandbox Runtime Isolation
Untrusted third-party sequencing inputs are handled within isolated workers. These workers run in restricted memory environments to prevent unauthorized system access or execution.

### 5.2 Dynamic HIPAA Verification
Automated checks continuously verify that all input payloads are anonymized before being saved or exported. Any records containing personal identifiers (e.g., names, locations) are rejected before analysis begins.
